Insmed reported $-131145000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
DBV Technologies DBVT:US USD -17287000 5.75M
Acelrx Pharmaceuticals ACRX:US USD -6750000 77.41M
Alimera Sciences ALIM:US USD -5257000 2.14M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Cytokinetics CYTK:US USD -142310000 122.49M
Gilead Sciences GILD:US USD 1.79B 645M
Insmed INSM:US USD -131145000 35.5M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Novartis NVS:US USD 1.57B 121M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Seattle Genetics SGEN:US USD -190816000 55.99M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M